Literature DB >> 6827615

Cephalosporins: recent developments.

A Kumar.   

Abstract

Cephalosporin antibiotics have attained a significant role in managing bacterial diseases. The author discusses the second- and third-generation cephalosporins in this review.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6827615      PMCID： PMC2561450     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  17 in total

1.  Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics.

Authors:  C M Ginsburg; G H McCracken
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

2.  Treatment of acute otitis media of infancy with cefaclor.

Authors:  J D Nelson; C M Ginsburg; J C Clahsen; L H Jackson
Journal:  Am J Dis Child       Date:  1978-10

3.  Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.

Authors:  W H Hall; B J Opfer; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

4.  Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole.

Authors:  J P Sosna; P R Murray; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

5.  Concentration of cefamandole in serum interstitial fluid, bile, and urine.

Authors:  N G Waterman; H U Eickenberg; L Scharfenberger
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

6.  Clinical pharmacology of cefadroxil in infants and children.

Authors:  C M Ginsburg; G H McCracken; J C Clahsen; M L Thomas
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

7.  MORPHOLOGICAL CHANGES IN GRAM-NEGATIVE BACILLI EXPOSED TO CEPHALOTHIN.

Authors:  T W CHANG; L WEINSTEIN
Journal:  J Bacteriol       Date:  1964-12       Impact factor: 3.490

8.  Pharmacokinetics of cefaclor in infants and children.

Authors:  G H McCracken; C M Ginsburg; J C Clahsen; M L Thomas
Journal:  J Antimicrob Chemother       Date:  1978-11       Impact factor: 5.790

9.  Intravenous cefotaxime in children with bacterial meningitis.

Authors:  B H Belohradsky; K Bruch; D Geiss; D Kafetzis; W Marget; G Peters
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

10.  LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.